← Back to Search

TREAT-ON for Diabetes (TREAT-ON Trial)

N/A

Waitlist Available

Led By Linda Siminerio, RN, PhD, CDE

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change every 3 months for 12 months total

Awards & highlights

TREAT-ON Trial Summary

This trial will help to improve diabetes outcomes by implementing a model of care that includes diabetes educator-led planned visits, with a real-time videoconferencing telemedicine program for ongoing patient support.

TREAT-ON Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change every three months for 12 months total

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change every three months for 12 months total

This trial's timeline: 3 weeks for screening, Varies for treatment, and change every three months for 12 months total for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change From Baseline in Glycemic Control

Secondary outcome measures

Change From Baseline in Diabetes Distress Across 3 Month Intervals for 12 Months

Change From Baseline in Diabetes Empowerment Across 3 Month Intervals for 12 Months

Change From Baseline in Diabetes Self-care Behavior [Diet] Across 3 Month Intervals for 12 Months.

+2 more

TREAT-ON Trial Design

2Treatment groups

Experimental Treatment

Group I: Usual CareExperimental Treatment1 Intervention

Group II: InterventionExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Usual Care

1990

Completed Phase 4

~7700

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor

1,719 Previous Clinical Trials

16,342,298 Total Patients Enrolled

19 Trials studying Diabetes

108,620 Patients Enrolled for Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,356 Previous Clinical Trials

4,315,023 Total Patients Enrolled

107 Trials studying Diabetes

138,663 Patients Enrolled for Diabetes

Linda Siminerio, RN, PhD, CDEPrincipal InvestigatorUniversity of Pittsburgh

4 Previous Clinical Trials

5,236 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any slots still available for volunteers to participate in the study?

"Clinicaltrials.gov has confirmed that this study, which was initially published on February 4th 2020 and revised as recently as September 8th 2022, is no longer recruiting patients at the present time. However, 1174 other trials are actively enrolling volunteers right now."

Answered by AI

What criteria must be met to qualify for this research project?

"This clinical trial is searching for 43 individuals between 18 and 75 years of age who have been diagnosed with diabetes mellitus. Most notably, the control group must be comprised of people that are already participating in UPMC Health Plan's Diabetes High Risk Initiative program."

Answered by AI

Can minors partake in this medical experiment?

"According to the parameters of this clinical trial, all participants must be between 18-75 years old. For patients younger or older than that range, there are 185 and 877 studies respectively offering suitable options."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Telemedicine for Reach, Education, Access and Treatment-ongoing

Linda Siminerio 2020. "Telemedicine for Reach, Education, Access and Treatment-ongoing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04107935.